L. Browne

L. Browne

Chairman at Rythera Therapeutics, Inc.

63 year
Health Technology
Consumer Services
Process Industries

Profile

L.
Daniel Browne
was the founder of Revance Therapeutics, Inc. (founded in 1999) where he held the title of President, Chief Executive Officer & Director from 2014 to 2019.
Currently, he is the Chairman at Rythera Therapeutics, Inc. (since 2020), a Director at Galderma Holding SA, and an Independent Director at Galderma Group AG (since 2022).
In the past, he served as the President & Chief Executive Officer of Neomend, Inc. (2001-2003) and Prograft Medical, Inc. (1997-2000).
He also served as a Director at Avava, Inc. (2020-2022) and held a Business Leader position at W.
L.
Gore & Associates, Inc. Mr. Browne completed his undergraduate degree at the University of Hawai'i at Hilo and holds an MBA from Pepperdine Graziadio Business School.

L. Browne active positions

CompaniesPositionStart
Director/Board Member -
Rythera Therapeutics, Inc. Chairman 31/08/2020
All active positions of L. Browne

Former positions of L. Browne

CompaniesPositionEnd
Director/Board Member 30/04/2022
REVANCE THERAPEUTICS, INC. Founder 13/10/2019
Chief Executive Officer -
Prograft Medical, Inc. Chief Executive Officer -
Corporate Officer/Principal -
See the detail of L. Browne's experience

Training of L. Browne

University of Hawai'i at Hilo Undergraduate Degree
Pepperdine Graziadio Business School Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of L. Browne's experience

Connections

61

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
REVANCE THERAPEUTICS, INC.

Health Technology

Private companies6

Health Technology

Process Industries

Prograft Medical, Inc.

Health Technology

Rythera Therapeutics, Inc.

Technology Services

See company connections